Published in J Clin Invest on June 01, 1983
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A (1986) 1.50
Albumin binding of unconjugated [3H]bilirubin and its uptake by rat liver basolateral plasma membrane vesicles. Biochem J (1996) 1.46
Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc Natl Acad Sci U S A (1988) 1.34
Influence of Cl- on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver. J Clin Invest (1987) 1.27
Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest (1985) 1.16
Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter. J Clin Invest (1991) 1.03
Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci U S A (1990) 0.99
Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome. Hepatology (2008) 0.97
Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein. J Clin Invest (1986) 0.93
Immunological studies of an organic anion-binding protein isolated from rat liver cell plasma membrane. J Clin Invest (1985) 0.86
Bilitranslocase and sulfobromophthalein/bilirubin-binding protein are both involved in the hepatic uptake of organic anions. Proc Natl Acad Sci U S A (1993) 0.83
Expression and function of renal and hepatic organic anion transporters in extrahepatic cholestasis. World J Gastroenterol (2012) 0.79
Organic anion uptake by hepatocytes. Compr Physiol (2014) 0.78
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Diffusion-in-gel methods for immunological analysis. Prog Allergy (1958) 27.50
High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol (1969) 20.26
Electron microscopic examination of subcellular fractions. I. The preparation of representative samples from suspensions of particles. J Cell Biol (1967) 3.77
The site of diphosphoinositide synthesis in rat liver. Biochem Biophys Res Commun (1965) 3.49
Efficient fluorography of 3H and 14C on thin layers. Anal Biochem (1978) 2.67
Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances. Science (1981) 2.22
Plasma membranes of the rat liver. Isolation and enzymatic characterization of a fraction rich in bile canaliculi. J Cell Biol (1969) 1.95
Recent advances in the separation and analysis of diazo-positive bile pigments. Methods Biochem Anal (1974) 1.81
Isoagglutinins associated with ABO erythroblastosis. J Clin Invest (1961) 1.76
Taurocholate transport by rat liver sinusoidal membrane vesicles: evidence of sodium cotransport. Hepatology (1982) 1.57
Hepatic organic anion uptake in the rat. J Clin Invest (1975) 1.49
THE PROTEIN-BINDING OF C14-BILIRUBIN IN HUMAN AND MURINE SERUM. J Clin Invest (1963) 1.49
Demonstration of binding sites for IgG Fc and the third complement component (C3) on isolated hepatocytes. J Immunol (1976) 1.36
The fate of bilirubin-IXalpha glucuronide in cholestasis and during storage in vitro. Intramolecular rearrangement to positional isomers of glucuronic acid. Biochem J (1978) 1.35
Kinetics of taurocholate uptake by the perfused rat liver. Gastroenterology (1975) 1.30
Identification, purification, and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. J Clin Invest (1980) 1.28
Albumin helps mediate removal of taurocholate by rat liver. J Clin Invest (1981) 1.26
Binding of sulfobromophthalein (BSP) sodium by plasma albumin. Its role in hepatic BSP extraction. J Clin Invest (1966) 1.23
Identification and characterization of a bile acid receptor in isolated liver surface membranes. J Clin Invest (1976) 1.22
A new method for the measurement of dissociation rates for complexes between small ligands and proteins as applied to the palmitate and bilirubin complexes with serum albumin. Biochim Biophys Acta (1974) 1.19
Solubilization and polyacrylamide gel electrophoresis of membrane enzymes with detergents. Methods Enzymol (1974) 1.17
Hepatocellular uptake of taurocholate in the dog. J Clin Invest (1975) 1.14
Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol (1981) 1.07
Bile salt binding to serum components. Taurocholate incorporation into high-density lipoprotein revealed by photoaffinity labelling. Eur J Biochem (1979) 1.04
Studies on the biosynthesis production of bilirubin-C14: an improved method utilizing delta-aminolevulinic acid-4-C14 in dogs. J Lab Clin Med (1966) 1.03
Effect of trypsin, phospholipases, and membrane-impermeable reagents on the uptake of palmitic acid by isolated rat liver cells. Arch Biochem Biophys (1974) 1.02
Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis. Biochim Biophys Acta (1983) 1.01
Binding of unconjugated and conjugated sulfobromophthalein to rat liver plasma membrane fractions in vitro. Biochim Biophys Acta (1981) 1.01
Characterization of rat liver cell plasma membranes. Proc Soc Exp Biol Med (1975) 1.01
Studies of oleate binding to rat liver plasma membranes. Biochem Biophys Res Commun (1983) 0.98
Sex differences in hepatic uptake of long chain fatty acids in single-pass perfused rat liver. J Lipid Res (1981) 0.94
Isolation of an organic anion binding protein from rat liver plasma membrane fractions by affinity chromatography. Biochem Biophys Res Commun (1979) 0.94
Kinetics of hepatic uptake of unconjugated bilirubin. Clin Sci Mol Med (1976) 0.93
Isolation of a sulfobromophthalein-binding protein from hepatocyte plasma membrane. Biochim Biophys Acta (1978) 0.93
High capacity chemisorbents for protein immobilization. Nat New Biol (1972) 0.93
The role of albumin in hepatic uptake processes. Prog Liver Dis (1982) 0.91
Further studies on bilitranslocase, a plasma membrane protein involved in hepatic organic anion uptake. Biochim Biophys Acta (1982) 0.90
Biliary transport of cholephilic dyes: evidence for two different pathways. Am J Physiol (1977) 0.89
Dissociation rate of serum albumin-fatty acid complex from stop-flow dielectric study of ligand exchange. Biophys J (1978) 0.86
Bromsulfophthalein uptake by isolated liver parenchymal cells. Biochem Biophys Res Commun (1976) 0.84
The composition of phospholipids in outer and inner mitochondrial membranes from guinea-pig liver. Biochim Biophys Acta (1970) 0.84
A simple procedure for the isolation of bilirubin monoglucuronide and diglucuronide from bile. J Lab Clin Med (1982) 0.84
Different pathways for hepatic uptake of taurocholate and indocyanine green. Experientia (1975) 0.80
Effect of organic anions on bile acid uptake by isolated rat hepatocytes. Hoppe Seylers Z Physiol Chem (1978) 0.80
Effect of fasting on organic anion uptake by isolated rat liver cells. Hepatology (1982) 0.80
Effect of graded bilirubin loads on bilirubin transport by perfused rat liver. Am J Physiol (1976) 0.80
Determination of association and dissociation rate constants for bilirubin--bovine serum albumin. Arch Biochem Biophys (1975) 0.78
Determination of neuraminidase-susceptible and total N-acetylneuraminic acid in cells by selected ion monitoring. Anal Biochem (1978) 0.77
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med (1991) 4.68
Long-term survival in patients with hereditary hemochromatosis. Gastroenterology (1996) 4.00
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest (1968) 3.66
A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab (1999) 3.00
Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases. Blood (1968) 2.73
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy (2006) 2.24
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis. Aliment Pharmacol Ther (2014) 2.15
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol (1986) 2.10
Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol (1997) 2.09
Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med (1989) 2.09
Mechanochemical properties of brain clathrin: interactions with actin and alpha-actinin and polymerization into basketlike structures or filaments. Proc Natl Acad Sci U S A (1979) 2.04
HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med (1992) 2.03
The aetiological agent of cat scratch disease. Lancet (1985) 1.93
Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas. N Engl J Med (1975) 1.92
Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr (1986) 1.89
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86
Clinical aspects of IgE myeloma. N Engl J Med (1969) 1.85
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Constitutional hepatic dysfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med (1970) 1.80
Micronitrous acid extraction-coagglutination test for rapid diagnosis of streptococcal pharyngitis. J Clin Microbiol (1983) 1.79
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74
Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr (1985) 1.73
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Hepatology (1998) 1.72
Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol (1974) 1.70
Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol (1973) 1.65
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ (2004) 1.62
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60
Telomerase activity in precancerous hepatic nodules. Cancer (1998) 1.59
Molecular forms of antihaemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol (1970) 1.57
Latex agglutination tests for rapid identification of group A streptococci directly from throat swabs. J Pediatr (1984) 1.56
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55
Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology (1996) 1.53
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N Engl J Med (1981) 1.52
Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol (1994) 1.52
Late diagnosis of Wilson's disease in a case without onset of symptoms. Acta Neurol Scand (1995) 1.52
Hepatology and hepatology: the trends continue. Hepatology (1995) 1.52
Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis (1992) 1.51
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A (1986) 1.50
Hepatic organic anion uptake in the rat. J Clin Invest (1975) 1.49
Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet (1990) 1.49
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Studies of bilirubin kinetics in normal adults. J Clin Invest (1969) 1.47
Culturing of throat swabs: end of an era? J Pediatr (1985) 1.45
Molecular and cellular pathology of hepatitis B. Lab Invest (1985) 1.43
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J Clin Invest (1976) 1.43
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol (1993) 1.42
The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med (1998) 1.42
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun (2001) 1.40
Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol (1997) 1.35
Distribution of five antigens in hepatocellular carcinoma. Lab Invest (1979) 1.35
Immune complexes in hepatocytic nuclei of HB ag-positive chronic hepatitis. N Engl J Med (1976) 1.35
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol (2005) 1.34
Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc Natl Acad Sci U S A (1988) 1.34
Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci (1997) 1.34
Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol (1998) 1.30
Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry. Scand J Gastroenterol (2004) 1.29
Defective bromosulfophthalein clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome). Gastroenterology (1972) 1.28
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Structure of the carbohydrate units of IgE immunoglobulin. II. Sequence of the sialic acid-containing glycopeptides. J Biol Chem (1974) 1.27